Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer

Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer

US Patent 12186404 · Granted Jan 7, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Radiotherapeutic and companion imaging agents to target MC1R2025
Method for determining corrective film pattern to reduce semiconductor wafer bow2025
Tumor-infiltrating lymphocytes for adoptive cell therapy2025
Melanocortin 1 receptor ligands and methods of use2024
Cyclic peptide compounds and methods of use thereof2024
Tumor-infiltrating lymphocytes for adoptive cell therapy2022
Molecular imaging of cancer cells in vivo2022
Toll-like receptor 2 ligands and methods of making and using thereof2022
Toll-like receptor 2 ligands and methods of making and using thereof2022
Radiotherapeutic and companion imaging agents to target MC1R2022
Radiotherapeutic and companion imaging agents to target MC1R2022
Coated, antimicrobial, chemically strengthened glass and method of making2022